ECM Therapeutics, Inc.

WARRENDALE, PA · Founded 2017 · CIK 0001743104 · Biotech · Private

Extracellular matrix-based therapeutic platforms for targeted tissue regeneration

ecmtherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$919K
1 Form D · Jun 2018
100 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$919,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2359Metalytics, LLC——
2360OLIGOMERIX INC—$2.9M
2361Allinaire Therapeutics, LLC—$950K
2362ECM Therapeutics, Inc.—$919K
2363ACRIGEN BIOSCIENCES, INC.—$775K
2364MARCH BIOSCIENCES INC—$22M
2365Biodesy LLC—$350K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Stephen BadylakDirector · Executive Officer
  • Katie CollinsDirector · Executive Officer
  • Jenna DzikiExecutive Officer
  • Paul FaganDirector · Executive Officer
  • George HusseyExecutive Officer
  • Lindsey SaldinExecutive Officer
  • Christine SheehyExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.